OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
July 20, 2024
PluriCDMO, Pluri's newly launched CDMO division, has been selected by Kadimastem to manufacture two novel cell therapy product candidates.
July 10, 2024
The acquisition of uniQure’s Lexington, Mass., manufacturing operations will boost Genezen’s late-phase and commercial gene therapy development and manufacturing services.
July 06, 2024
The increased demand for biopharmaceutical products is increasing the demand for lyophilization innovations and services.
July 04, 2024
HCPs are major process-related impurities that must be monitored throughout biologics production for clearance.
July 02, 2024
This collaboration aims to support and accelerate clinical development of advanced and novel technologies.
Webinar Date/Time: Thu, Jul 25, 2024 11:00 AM EDT
July 01, 2024
The ROSS Model HSM-405SC-25 Inline High Shear Mixer features a built-in workbench and is designed for production floors that require flexibility.
The VIOS family of incubators are known for optimal cell growth conditions and minimal contamination risk.
The US currently relies heavily on imports from China and other overseas nations for APIs needed to manufacture drug products of critical importance to US patients.
June 27, 2024
No timetable was given for the length of the planned evaluation or when data would be available, but Kite intends to use the information to expand its manufacturing options.